PLMR (NASDAQ: PLMR) holder plans Rule 144 sales of common shares

Rhea-AI Filing Summary

A holder of common stock in symbol PLMR has filed a notice of proposed sales under Rule 144. The filing lists three planned NASDAQ transactions of 1,260, 428, and 2,566 shares, with aggregate market values of 157,437, 53,479, and 320,622, respectively. All trades are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, with expected sale dates of January 29, 2026 and January 31, 2026.

The securities were acquired from the issuer as restricted stock and performance stock, treated as compensation. Acquisitions occurred on January 29, 2026 and January 31, 2026, with corresponding payment dates the same days. The signer represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	1260	157437	26494524	01/29/2026	NASDAQ
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	428	53479	26494524	01/31/2026	NASDAQ
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	2566	320622	26494524	01/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/29/2026	Restricted Stock	Issuer			2100	01/29/2026	Compensation
Common	01/31/2026	Restricted Stock	Issuer			713	01/31/2026	Compensation
Common	01/31/2026	Performance Stock	Issuer			4276	01/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PLMR Rule 144 notice disclose?

The notice discloses planned sales of PLMR common stock under Rule 144. It details three proposed NASDAQ transactions, listing share counts, aggregate market values, anticipated sale dates in January 2026, the broker involved, and that the shares were originally received from the issuer as stock-based compensation.

How many PLMR shares are planned for sale and on which dates?

The filing lists three proposed sales of PLMR common shares. Planned trades cover 1,260 shares on January 29, 2026, and 428 and 2,566 shares on January 31, 2026, each with specified aggregate market values and all to be executed on the NASDAQ market.

How were the PLMR shares in this Rule 144 filing originally acquired?

The shares were acquired from the issuer as equity compensation. The filing describes the securities as restricted stock and performance stock obtained directly from the issuer on January 29, 2026 and January 31, 2026, with compensation identified as the nature of payment for these awards.

Which broker is handling the planned PLMR Rule 144 stock sales?

Morgan Stanley Smith Barney LLC Executive Financial Services is handling the trades. The notice specifies this broker, including its New York address, as the firm through which all three proposed NASDAQ sales of PLMR common stock will be executed under the Rule 144 plan.

What representation does the seller make about PLMR in the Rule 144 form?

The seller represents they know no undisclosed material adverse information. By signing, the person for whose account the securities will be sold affirms they are unaware of material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.